A Multicenter Randomized Double Blind Placebo Controlled Dose Ranging Study of Orally Administered Recombinant Human Interleukin-11 (rhIL-11) for the Treatment of Patients with Active Crohn's Disease

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/15/033/31/07